Phase 1 Study of M9466 Combined With Carboplatin and Platinum-based Anticancer Therapy (DDRiver 521)
EMD Serono
EMD Serono
AbbVie
Incyte Corporation
Queen Mary University of London
Fox Chase Cancer Center
Gilead Sciences
Hoffmann-La Roche
Maastricht Radiation Oncology
M.D. Anderson Cancer Center
Virginia Commonwealth University
The University of Texas Health Science Center at San Antonio
Memorial Sloan Kettering Cancer Center
University of California, San Francisco
AstraZeneca